Retail Pharmacy Closures Leave Low-Income Neighborhoods Without Prescription Access

The Quiet Collapse of Corner Pharmacies

When a pharmacy shuts down in a wealthy suburb, residents typically drive a few extra miles to the next chain location. When a pharmacy shuts down in a low-income urban neighborhood or a rural county with one grocery store, something more serious happens: people stop filling prescriptions. That gap between inconvenience and genuine medical crisis defines what is now a growing public health problem tied directly to retail economics.

Major pharmacy chains have closed thousands of locations over the past several years, citing thin margins, retail theft losses, and the accelerating shift toward mail-order and online pharmacy models. The closures have not been distributed evenly. Locations in high-poverty zip codes, predominantly Black and Latino communities, and rural areas have closed at higher rates than locations in wealthier, denser markets – a pattern that compounds existing inequalities in healthcare access.

Why Pharmacies Are Pulling Out

The business logic behind pharmacy closures is not complicated. Retail pharmacies operate on margins that have been squeezed for years by pharmacy benefit managers (PBMs), the middlemen who negotiate drug pricing between insurers and pharmacies. Independent pharmacies have complained for years that reimbursement rates from PBMs sometimes fall below the actual cost of dispensing a medication. Chain pharmacies face the same pressure at scale, and when a location is not generating enough foot traffic from higher-margin front-end retail sales – vitamins, cosmetics, seasonal goods – the prescription business alone rarely justifies keeping the doors open.

Low-income neighborhoods create a particular bind. Medicaid reimbursement rates are generally lower than commercial insurance rates, so a pharmacy serving a predominantly Medicaid population is already working with a thinner revenue base. Add lower front-end retail sales, higher operational costs in some urban markets, and security concerns that have driven up insurance expenses, and the financial case for staying becomes difficult to make. Corporate pharmacy networks are increasingly making decisions based on per-store profitability, and stores in underserved areas tend to lose that calculation.

What Happens When the Pharmacy Closes

The most direct consequence is what public health researchers call a “pharmacy desert” – a geographic area where residents face significant distance barriers to accessing a pharmacy. The threshold definitions vary, but the practical problem is consistent: patients with chronic conditions who need regular medication refills are suddenly looking at transportation challenges that many cannot solve.

For someone managing diabetes, hypertension, or a psychiatric condition, a missed prescription refill is not simply an inconvenience. Unmanaged diabetes leads to emergency room visits. Untreated hypertension leads to strokes. Interrupted psychiatric medication can lead to hospitalization. These downstream costs fall heavily on emergency departments and Medicaid budgets – making pharmacy closures in low-income areas an economic problem, not just a healthcare access problem.

Transportation is a concrete barrier that is easy to underestimate. A round trip to a pharmacy several miles away may require two bus transfers and two hours for someone without a car. For elderly patients, for parents with young children, for anyone working multiple jobs without flexibility, that trip becomes something they skip. Mail-order pharmacy options, frequently offered as an alternative solution, require reliable home delivery, a stable address, and enough advance planning to order medications before running out – conditions that do not always exist for people in unstable housing situations.

Independent pharmacies, which have historically filled access gaps in some underserved communities, are also under severe pressure. The same PBM reimbursement dynamics that squeeze chain pharmacies hit independent operators even harder, because they lack the negotiating leverage and operational scale of national networks. When an independent pharmacy closes in a rural town, there is no backup chain location five minutes away.

The Policy Gap

Federal and state governments have been slow to treat pharmacy access as infrastructure in the way they treat hospital access. Certificate of Need laws in many states regulate hospital closures and require regulatory review before a hospital can shut down a service line, but no equivalent framework exists for pharmacies. A chain can close a location with minimal public notice, and no regulatory body has the authority to prevent it or require a transition plan for patients.

Some state Medicaid programs have introduced enhanced reimbursement rates for pharmacies operating in underserved areas, and a small number of states have moved to cap certain PBM practices that reduce reimbursements below dispensing costs. These measures are narrow and inconsistently applied. The Federal Trade Commission has been scrutinizing PBM practices more aggressively, but the gap between regulatory attention and meaningful change in pharmacy access remains wide.

Who Absorbs the Cost

When patients cannot access their medications, the costs do not disappear – they migrate. Emergency departments see higher volumes of patients whose conditions deteriorated because of medication gaps. Medicaid programs pay for hospitalizations that could have been prevented by a $15 prescription. Primary care providers spend more time managing acute crises that should have been routine maintenance visits.

Federally Qualified Health Centers (FQHCs), which serve low-income populations and operate under federal grant funding, often step in to provide medication dispensing services in areas with no pharmacy access, but they are not designed to function as retail pharmacies and lack the capacity to fill that role broadly. Community health workers are increasingly being asked to help patients navigate medication access, adding to their workload without adding to the pharmacy supply.

The practical question no one has answered satisfactorily is what fills the space when a pharmacy closes in a neighborhood where opening a replacement is not financially attractive to any operator. Telepharmacy models – where a pharmacist supervises remotely through video while a technician dispenses locally – have shown promise in rural settings, but require infrastructure investment and regulatory frameworks that have not been developed consistently across states. Without some form of subsidy, grant program, or regulatory incentive, the market alone will not put a pharmacy back in a neighborhood where the economics drove the last one out.